169
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Aerosolized scopolamine protects against microinstillation inhalation toxicity to sarin in guinea pigs

, , , , , , , & show all
Pages 463-472 | Received 03 Dec 2010, Accepted 08 Feb 2011, Published online: 08 Jun 2011

References

  • Ahmed S, Sileno AP, deMeireles JC, Dua R, Pimplaskar HK, Xia WJ, Marinaro J, Langenback E, Matos FJ, Putcha L, Romeo VD, Behl CR. 2000. Effects of pH and dose on nasal absorption of scopolamine hydrobromide in human subjects. Pharm Res 17:974–977.
  • Allon N, Rabinovitz I, Manistersky E, Weissman BA, Grauer E. 2005. Acute and long-lasting cardiac changes following a single whole-body exposure to sarin vapor in rats. Toxicol Sci 87:385–390.
  • Anderson DR, Gennings C, Carter WH, Harris LW, Lennox WJ, Bowersox SL, Solana RP. 1994. Efficacy comparison of scopolamine and diazepam against soman-induced debilitation in guinea pigs. Fundam Appl Toxicol 22:588–593.
  • Anderson DR, Harris LW, Chang FC, Baze WB, Capacio BR, Byers SL, Lennox WJ. 1997. Antagonism of soman-induced convulsions by midazolam, diazepam and scopolamine. Drug Chem Toxicol 20:115–131.
  • Anzueto A, Berdine GG, Moore GT, Gleiser C, Johnson D, White CD, Johanson WG Jr. 1986. Pathophysiology of soman intoxication in primates. Toxicol Appl Pharmacol 86:56–68.
  • Anzueto A, deLemos RA, Seidenfeld J, Moore G, Hamil H, Johnson D, Jenkinson SG. 1990. Acute inhalation toxicity of soman and sarin in baboons. Fundam Appl Toxicol 14:676–687.
  • Bottoms GD, Fessler JF, Pfeifer CA, Johnson M, Roesel OF, Voorhees WD. 1991. The effects of soman poisoning in combination with hypovolemic shock. Fundam Appl Toxicol 16:622–635.
  • Buchanan KC, Burge RR, Ruble GR. 1998. Evaluation of injectable anesthetics for major surgical procedures in guinea pigs. Contemp Top Lab Anim Sci 37:58–63.
  • Capacio BR, Shih TM. 1991. Anticonvulsant actions of anticholinergic drugs in soman poisoning. Epilepsia 32:604–615.
  • Chang FC, Foster RE, Beers ET, Rickett DL, Filbert MG. 1990. Neurophysiological concomitants of soman-induced respiratory depression in awake, behaving guinea pigs. Toxicol Appl Pharmacol 102:233–250.
  • Chang FC, Gouty SC, Eder LC, Hoffman BE, Maxwell DM, Brecht KM. 1998. Cardiorespiratory effects of O-isobutyl S-[2-(diethylamino)-ethyl] methylphosphonothioate− a structural isomer of VX. J Appl Toxicol 18:337–347.
  • Che MM, Conti M, Boylan M, Sciuto AM, Gordon RK, Nambiar MP. 2008. Blood and bronchoalveolar lavage fluid acetylcholinesterase levels following microinstillation inhalation exposure to sarin in guinea pigs. Inhal Toxicol 20:821–828.
  • Che MM, Conti M, Chanda S, Boylan M, Sabnekar P, Rezk P, Amari E, Sciuto AM, Gordon RK, Doctor BP, Nambiar MP. 2009. Post-exposure treatment with nasal atropine methyl bromide protects against microinstillation inhalation exposure to sarin in guinea pigs. Toxicol Appl Pharmacol 239:251–257.
  • Chinn HI, Hyde RW, Milch LJ. 1955. Prevention and treatment of motion sickness by intranasal medication. Proc Soc Exp Biol Med 90:666–669.
  • Conti ML, Che MM, Boylan M, Sciuto AM, Gordon RK, Nambiar MP. 2009. Acute microinstillation inhalation exposure to sarin induces changes in respiratory dynamics and functions in guinea pigs. Int J Toxicol 28:436–447.
  • Costantino HR, Illum L, Brandt G, Johnson PH, Quay SC. 2007. Intranasal delivery: Physicochemical and therapeutic aspects. Int J Pharm 337:1–24.
  • De Candole CA, Douglas WW, Evans CL, Holmes R, Spencer KE, Torrance RW, Wilson KM. 1953. The failure of respiration in death by anticholinesterase poisoning. Br J Pharmacol Chemother 8:466–475.
  • Decandole CA. 1962. Medical aspects of chemical warfare. Can Med Assoc J 87:1187–1192.
  • DeLorenzo RA. 2001. Exposed. Signs, symptoms & EMS management of nerve-agent poisoning. JEMS 26:48–57.
  • Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95.
  • Franz DR, Hilaski R. 1990. Sequence of cardiorespiratory effects of soman altered by route of administration. Toxicol Lett 51:221–225.
  • Graham JR, Wright BS, Rezk PE, Gordon RK, Sciuto AM, Nambiar MP. 2006. Butyrylcholinesterase in guinea pig lung lavage: A novel biomarker to assess lung injury following inhalation exposure to nerve agent VX. Inhal Toxicol 18:493–500.
  • Harris LW, Gennings C, Carter WH, Anderson DR, Lennox WJ, Bowersox SL, Solana RP. 1994. Efficacy comparison of scopolamine (SCP) and diazepam (DZ) against soman-induced lethality in guinea pigs. Drug Chem Toxicol 17:35–50.
  • Henderson RF. 2005. Use of bronchoalveolar lavage to detect respiratory tract toxicity of inhaled material. Exp Toxicol Pathol 57 Suppl 1:155–159.
  • Hyde RW, Tonndorf J, Chinn HI. 1953. Absorption from the nasal mucous membrane. Ann Otol Rhinol Laryngol 62:957–968.
  • Janowsky DS. 2002. Central anticholinergics to treat nerve-agent poisoning. Lancet 359:265–266.
  • Janowsky DS, Berkowitz A, Turken A, Risch SC. 1985a. Antagonism of physostigmine induced lethality by a combination of scopolamine and methscopolamine. Acta Pharmacol Toxicol (Copenh) 56:154–157.
  • Janowsky DS, Davis JM, Overstreet DH. 2004. Antagonism of anticholinesterase (DFP) toxicity by donepezil plus scopolamine: A preliminary study. Pharmacol Biochem Behav 77:337–343.
  • Janowsky DS, Drennan M, Berkowitz A, Turken A, Risch SC. 1985b. Comparative effects of scopolamine and atropine in preventing cholinesterase inhibitor induced lethality. Mil Med 150:693–695.
  • Janowsky DS, Risch SC, Huey LY. 1985c. Central cardiovascular effects of physostigmine in humans. Hypertension 7:140–145.
  • Janowsky DS, Risch SC, Huey LY, Kennedy B, Ziegler M. 1985d. Effects of physostigmine on pulse, blood pressure, and serum epinephrine levels. Am J Psychiatry 142:738–740.
  • Janowsky DS, Risch SC, Kennedy B, Ziegler MG, Huey LY. 1986. Acute effects of physostigmine and neostigmine in man. Mil Med 151:48–51.
  • Kassa J, Fusek J. 2000. The influence of anticholinergic drug selection on the efficacy of antidotal treatment of soman-poisoned rats. Toxicology 154:67–73.
  • Ketchum JS, Sidell FR, Crowell EB Jr, Aghajanian GK, Hayes AH Jr. 1973. Atropine, scopolamine, and ditran: Comparative pharmacology and antagonists in man. Psychopharmacologia 28:121–145.
  • Kventsel I, Berkovitch M, Reiss A, Bulkowstein M, Kozer E. 2005. Scopolamine treatment for severe extra-pyramidal signs following organophosphate (chlorpyrifos) ingestion. Clin Toxicol (Phila) 43:877–879.
  • Lipp JA, Dola TJ. 1978. Effect of atropine upon the cerebrovascular system during soman-induced respiratory depression. Arch Int Pharmacodyn Ther 235:211–218.
  • Masuda N, Takatsu M, Morinari H, Ozawa T. 1995. Sarin poisoning in Tokyo subway. Lancet 345:1446.
  • McDonough JH Jr, Dochterman LW, Smith CD, Shih TM. 1995. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 16:123–132.
  • McDonough JH Jr, McMonagle J, Copeland T, Zoeffel D, Shih TM. 1999. Comparative evaluation of benzodiazepines for control of soman-induced seizures. Arch Toxicol 73:473–478.
  • McDonough JH Jr, Shih TM. 1993. Pharmacological modulation of soman-induced seizures. Neurosci Biobehav Rev 17:203–215.
  • McDonough JH Jr, Zoeffel LD, McMonagle J, Copeland TL, Smith CD, Shih TM. 2000. Anticonvulsant treatment of nerve agent seizures: Anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res 38:1–14.
  • Nambiar MP, Gordon RK, Moran TS, Richards SM, Sciuto AM. 2007a. A simple method for accurate endotracheal placement of an intubation tube in Guinea pigs to assess lung injury following chemical exposure. Toxicol Mech Methods 17:385–392.
  • Nambiar MP, Gordon RK, Rezk PE, Katos AM, Wajda NA, Moran TS, Steele KE, Doctor BP, Sciuto AM. 2007b. Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX. Toxicol Appl Pharmacol 219:142–150.
  • Nambiar MP, Wright BS, Rezk PE, Smith KB, Gordon RK, Moran TS, Richards SM, Sciuto AM. 2006. Development of a microinstillation model of inhalation exposure to assess lung injury following exposure to toxic chemicals and nerve agents in guinea pigs. Toxicol Mech Methods 16:295–306.
  • Niven AS, Roop SA. 2004. Inhalational exposure to nerve agents. Respir Care Clin N Am 10:59–74.
  • Pires A, Fortuna A, Alves G, Falcão A. 2009. Intranasal drug delivery: How, why and what for? J Pharm Pharm Sci 12:288–311.
  • Putcha L, Tietze KJ, Bourne DW, Parise CM, Hunter RP, Cintrón NM. 1996. Bioavailability of intranasal scopolamine in normal subjects. J Pharm Sci 85:899–902.
  • Raveh L, Weissman BA, Cohen G, Alkalay D, Rabinovitz I, Sonego H, Brandeis R. 2002. Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction. Neurotoxicology 23:7–17.
  • Rezk PE, Graham JR, Moran TS, Gordon RK, Sciuto AM, Doctor BP, Nambiar MP. 2007. Acute toxic effects of nerve agent VX on respiratory dynamics and functions following microinsillation inhalation exposure in guinea pigs. Inhal Toxicol 19:291–302.
  • Rickett DL, Glenn JF, Beers ET. 1986. Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicology 7:225–236.
  • Shih TM, Koviak TA, Capacio BR. 1991. Anticonvulsants for poisoning by the organophosphorus compound soman: Pharmacological mechanisms. Neurosci Biobehav Rev 15:349–362.
  • Shih TM, Rowland TC, McDonough JH. 2007. Anticonvulsants for nerve agent-induced seizures: The influence of the therapeutic dose of atropine. J Pharmacol Exp Ther 320:154–161.
  • Simmons RG, Phillips JB, Lojewski RA, Wang Z, Boyd JL, Putcha L. 2010. The efficacy of low-dose intranasal scopolamine for motion sickness. Aviat Space Environ Med 81:405–412.
  • Tonndorf J, Hyde RW, Chinn HI, Lett JE. 1953. Absorption from nasal mucous membrane: Systemic effect of hyoscine following intranasal administration. Ann Otol Rhinol Laryngol 62:630–641.
  • Vucemilovic A. 2010. [Toxicological effects of weapons of mass destruction and noxious agents in modern warfare and terrorism]. Arh Hig Rada Toksikol 61:247–256.
  • Wetherell J, Hall T, Passingham S. 2002. Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig. Neurotoxicology 23:341–349.
  • Worek F, Kleine A, Falke K, Szinicz L. 1995a. Arrhythmias in organophosphate poisoning: Effect of atropine and bispyridinium oximes. Arch Int Pharmacodyn Ther 329:418–435.
  • Worek F, Klimmek R, Szinicz L. 1995b. Effects of atropine and soman on the pharmacokinetics of the oxime HLö 7 dimethanesulfonate in anesthetized guinea-pigs. Drug Chem Toxicol 18:137–149.
  • Worek F, Szinicz L. 1993. Analysis of cardiovascular and respiratory effects of various doses of soman in guinea-pigs: Efficacy of atropine treatment. Arch Int Pharmacodyn Ther 325:96–112.
  • Wright BS, Rezk PE, Graham JR, Steele KE, Gordon RK, Sciuto AM, Nambiar MP. 2006. Acute lung injury following inhalation exposure to nerve agent VX in guinea pigs. Inhal Toxicol 18:437–448.
  • Wright PG. 1954. An analysis of the central and peripheral components of respiratory failure produced by anticholinesterase poisoning in the rabbit. J Physiol (Lond) 126:52–70.
  • Zhu H, Gao W, Jiang H, Jin QH, Shi YF, Tsim KW, Zhang XJ. 2007. Regulation of acetylcholinesterase expression by calcium signaling during calcium ionophore A23187- and thapsigargin-induced apoptosis. Int J Biochem Cell Biol 39:93–108.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.